Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Serge Belanger Maintained (VRCA) at Strong Buy with Decreased Target to $12 on, Aug 15th, 2024


Published on 2024-10-28 13:41:04 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $16 to $12 on, Aug 15th, 2024.

Serge has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Tuesday, May 14th, 2024
Contributing Sources